The HF-REVERT study is evaluating efficacy and safety of heart failure therapy
News
NHS app reaches new milestone
The NHS App enabled 1.8 million repeat prescriptions to be ordered in June 2022 alone
Aardex and Biocorp recruited by Trials@Home for phase 4 diabetes study
The decentralised clinical trial centre will combine Biocorp pen injector with Aardex’s software
AstraZeneca and Daiichi Sankyo’s Enhertu receives EU approval
Specifically engineered antibody treats HER2-positive metastatic breast cancer
Monkeypox cases prompt governments to order vaccine supply
Imvanex is a non-replicating smallpox vaccine developed in collaboration with the US government
EMA validates application for Byondis’ trastuzumab duocarmazine
The submission follows positive results of phase 3 trial focusing on breast cancer therapy
EC authorisation granted to kidney disease treatment Kinpeygo
The treatment was developed by Calliditas and will be marketed by Stada
Roche’s combination breast cancer treatment delivers positive results
Data from APHINITY study shows Roche’s Perjeta-based regimen reduces the risk of disease returning for people with HER2-positive early breast cancer
Bristol Myers Squibb’s Opdivo recommended by NICE for malignant pleural mesothelioma patients
Armed forces veterans and people who were exposed to asbestos could benefit from the therapy
NICE recommends Novartis’ Piqray therapy
Piqray is a targeted treatment for thousands of advanced breast cancer patients
Sanofi and Regeneron’s Dupixent shows positive results in phase 3 trial
Trial focusing on children with eosinophilic oesophagitis has met its primary endpoint
New data shows improved prophylactic effectiveness with Sobi’s Elocta
Annualised bleed rate among haemophilia A patients was significantly lower in real-world setting
NHS leaders voice stark staff warning
Changes to vocational BTEC healthcare qualifications could see reduction in new nurse recruits
VisionHealth and Boehringer Ingelheim link up for asthma
The partnership will deliver digital therapy support for asthma and COPD patients
Healx has new location at Chesterford Research Park
The lab will allow the Healx team to accelerate the discovery of potential new therapies for more rare conditions
